EPIVAX
EpiVax is an immunology company and has developed comprehensive analytical capabilities in the field of computational immunology.
EPIVAX
Industry:
Analytics Biotechnology Health Care Pharmaceutical
Founded:
1998-01-01
Address:
Providence, Rhode Island, United States
Country:
United States
Website Url:
http://www.epivax.com
Total Employee:
11+
Status:
Active
Contact:
4012727562
Email Addresses:
[email protected]
Total Funding:
4.64 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Antoxis
Antoxis is developing treatments for various neurological conditions.
Binnopharm
Binnopharm is a Russian full-cycle biopharmaceutical companies with its own R&D division
BioDuro
BioDuro is a US-based, fully-integrated, end-to-end global life science outsourcing services company with a team of over 630 in Beijing,
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Emerald Logic
Emerald Logic offers solutions for hyper-dimensional analytical problems in finance, social networking, defense and healthcare sectors.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
EVerZom
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.
GeneBiology
GeneBiology develops a patented new drugs for serious diseases using the 505(b)(2) regulatory pathway.
Tigermed
Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.
Cigna HealthSpring
HealthSpring is a health service company offering personalized healthcare solutions for Medicare and Medicaid beneficiaries in the U.S.
inviCRO
inviCRO is an imaging informatics company that offers full-service tissue-to-human imaging, analysis, and data management services.
Invitrogen Corporation
Invitrogen is one of several brands under the Thermo Fisher Scientific corporation.
Medpace
Medpace, Inc., a clinical research organization, provides clinical development services for pharmaceutical and biotechnology
Nemaura Pharma
Nemaura Pharma is a biotech company with headquarters and research facilities in the Advanced Technology Centre.
PhysioSonics
PhysioSonics, a development-stage device company based in Washington, focuses on ultrasound imaging to monitor blood flow in the brain.
RyMed Technologies
RyMed Technologies develops intraluminal protection products for intravenous catheter care and maintenance management.
TaiGen Biotechnology
TaiGen is a pharmaceutical company discovering, developing and commercializing drugs to treat cancers, infectious diseases and diabetics.
Vanrx Pharmasystems
Vanrx Pharmasystems manufactures aseptic filling machines that improve the production of sterile injectables.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - EpiVax
GBS/CIDP Foundation International
GBS/CIDP Foundation International investment in Grant - EpiVax
National Institutes of Health
National Institutes of Health investment in Grant - EpiVax
National Institutes of Health
National Institutes of Health investment in Grant - EpiVax
National Institutes of Health
National Institutes of Health investment in Grant - EpiVax
National Institutes of Health
National Institutes of Health investment in Grant - EpiVax
National Institutes of Health
National Institutes of Health investment in Grant - EpiVax
National Institutes of Health
National Institutes of Health investment in Grant - EpiVax
Slater Technology Fund
Slater Technology Fund investment in Seed Round - EpiVax
Official Site Inspections
http://www.epivax.com Semrush global rank: 8.82 M Semrush visits lastest month: 248
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "EpiVax"
EpiVax - Wikipedia
EpiVax is an American biotechnology company based in Rhode Island. The company was founded in 1998 by Anne Searls De Groot, who serves as its CEO and CSO. EpiVax holds the exclusive license to the EpiMatrix vaccine design technology. In 2020 it developed a COVID-19 vaccine, EPV-CoV19, in partnership with the University of Georgia and Immunomic Therapeutics. See details»
EpiVax - Crunchbase Company Profile & Funding
Organization. EpiVax . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... EpiVax is an immunology company and has …See details»
EpiVax, Inc. - LinkedIn
EpiVax uses immune-engineering to develop new vaccines and to improve the immunogenicity profiles of new drugs. The company is well known for its independent thinking and interdisciplinary scientists.See details»
EPIVAX, INC. Company Profile | Providence, RI - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for EPIVAX, INC. of Providence, RI. Get the latest business insights from Dun & Bradstreet.See details»
Epivax Inc - Company Profile and News - Bloomberg Markets
EpiVax, Inc. operates as a biotechnology research and development company. The Company specializes in computational immunology, vaccine design, engineering therapeutic proteins, …See details»
EpiVax Company Profile 2024: Valuation, Funding & Investors
When was EpiVax founded? EpiVax was founded in 1998. Where is EpiVax headquartered? EpiVax is headquartered in Providence, RI. What is the size of EpiVax? EpiVax has 48 total …See details»
Providence-based "Biotech start up" EpiVax Celebrates 25th …
May 17, 2023 EpiVax is an innovative research organization that develops computer algorithms and toolkits to assess immunogenicity and design vaccines, in addition to having invented a …See details»
EpiVax Therapeutics, Inc. - LinkedIn
EpiVax Therapeutics ("EVT"), founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or …See details»
iVAX: An integrated toolkit for the selection and optimization of ...
Beginning in 2002, Martin and De Groot at EpiVax have developed an integrated approach to computational vaccine design that was first described in 2003 at a seminal meeting organized …See details»
[PRNewswire] Providence-based "Biotech start up" EpiVax
In addition, EpiVax is celebrating the work of two not-for-profit organizations that have been partners with EpiVax for nearly all of those 25 years. EpiVax is an innovative research …See details»
On Eve of New Decade, EpiVax Re-Pledges Commitment to …
Dec 20, 2019 The majority of EpiVax's support is provided to non-profit organizations located in the adjacent neighborhood of Olneyville, Providence, R.I. Thinking globally, corporate in-kind …See details»
EpiVax Therapeutics Company Profile 2024: Valuation, Funding ...
EpiVax Therapeutics General Information Description. Operator of a clinical research and development platform intended to offer precision cancer immunotherapies. The company's …See details»
EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 …
Apr 7, 2020 /PRNewswire/ -- EpiVax, Inc., ... GVF is a 501(c)(3) organization that supports activities to advance healthcare accessibility and educational programs to inform the public …See details»
EpiVax Joins Intravacc, CEPI on Project to Develop Universal ...
Oct 31, 2022 EpiVax, Inc. announces participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic Preparedness Innovations), to develop universal vaccines for …See details»
EpiVax Accelerates COVID-19 Vaccine Development
Mar 5, 2020 EpiVax announces a collaboration to develop a novel coronavirus SARS-CoV-2 (COVID-19) vaccine with University of Georgia’s Ted Ross (Director, Center for Vaccines and …See details»
EpiVax Joins Intravacc, CEPI on Project to Develop Universal ...
PROVIDENCE, R.I., Oct. 31, 2022 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to announce participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic …See details»
EpiVax and EpiVax Therapeutics Advance COVID-19 Vaccine …
Dec 31, 2020 EpiVax's immunogenicity screening toolkits for therapeutics and vaccines, ISPRI and iVAX, are employed in advancing the research of a global roster of companies. For more …See details»
EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants
Nov 30, 2021 EPV-CoV-19 will boost T cell response, a key contributor to immune protection against SARS-CoV-2. Using proprietary immunoinformatics tools, EpiVax selected highly …See details»
EpiVax Identifies T cell Epitopes critical to robust T cell immune ...
May 17, 2021 EpiVax's immunogenicity screening toolkits for therapeutics and vaccines, ISPRI and iVAX, are employed in advancing the research of a global roster of companies. For more …See details»